Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.

Journal of clinical pathology - 1 Jan 2016

Song Dongjian, Yue Lifang, Wu Gang, Ma Shanshan, Yang Heying, Liu Qiuliang, Zhang Da, Xia Ziqiang, Jia Jia, Wang Jiaxiang

Abstract excerpt

AIMS: A member of the p53 family, the p73 gene is essential for the maintenance of genomic stability, DNA repair and apoptosis regulation. This study was designed to evaluate the utility of expression and DNA methylation patterns of the p73 gene in the early diagnosis and prognosis of Wilms' tumo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to Kaplan-Meier Estimate
Share to Kidney Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Real-Time Polymerase Chain Reaction

Share to ROC Curve

Share to Tumor Burden

Share to Tumor Protein p73

Share to Wilms Tumor

Source

Identifiers

PMID: 26184366
DOI: 10.1136/jclinpath-2015-203150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26184366-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.PMID 26184366Read ↗

Association of TP53 polymorphisms on the risk of Wilms tumor.Semantic proximity Read ↗

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations.Semantic proximity Read ↗

Association Between TP53 Mutation and Prognosis in Wilms Tumor: A Meta-Analysis.Semantic proximity Read ↗

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533Semantic proximity Read ↗

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.Semantic proximity Read ↗

Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms’ tumorSemantic proximity Read ↗

TRMT6 gene rs236110 C > A polymorphism increases the risk of Wilms tumor.Semantic proximity Read ↗

TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia.Semantic proximity Read ↗

Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.Semantic proximity Read ↗

Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.Semantic proximity Read ↗

The contribution of WTAP gene variants to Wilms tumor susceptibility.Semantic proximity Read ↗

Identification of Molecular Biomarkers in Taiwanese Patients with Wilms Tumor Using a Methylation-Specific Multiplex Ligation-Dependent Probe Amplification (MS-MLPA)-Based ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.